FDA Looking At Investigator Histories To Identify Problem Sponsors
Executive Summary
FDA plans to "link" drug company sponsors to the quality of data submitted by clinical investigators, Office of Compliance Director Stephanie Gray told the University of Texas at Austin's International Industrial Pharmacy Conference Feb. 25.
You may also be interested in...
Quintiles Rejects Buy-Out Offer From Founder Gillings, Weighs Options
Quintiles will look for potential buyers after rejecting an acquisition offer from founder and Chairman Dennis Gillings, PhD
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011